Xie LD - Search Results

1

The Impact of SGLT1 Inhibition on Frailty and Sarcopenia: A Mediation Mendelian Randomization Study.

Huang BB, Zhang YJ, Ruan GF, Yu X, Liu Q, Zhang MJ, Yu MZ, Chen A, Liang YB, Xie LD, Luo L. Huang BB, et al. Among authors: xie ld. J Cachexia Sarcopenia Muscle. 2024 Dec;15(6):2693-2704. doi: 10.1002/jcsm.13614. Epub 2024 Oct 30. J Cachexia Sarcopenia Muscle. 2024. PMID: 39474649 Free PMC article.

2

Silencing heat shock protein 27 (HSP27) inhibits the proliferation and migration of vascular smooth muscle cells in vitro.

Huang J, Xie LD, Luo L, Zheng SL, Wang HJ, Xu CS. Huang J, et al. Among authors: xie ld. Mol Cell Biochem. 2014 May;390(1-2):115-21. doi: 10.1007/s11010-014-1962-1. Epub 2014 Jan 28. Mol Cell Biochem. 2014. PMID: 24469469

3

Adipose-derived stem cells attenuate pulmonary arterial hypertension and ameliorate pulmonary arterial remodeling in monocrotaline-induced pulmonary hypertensive rats.

Luo L, Lin T, Zheng S, Xie Z, Chen M, Lian G, Xu C, Wang H, Xie L. Luo L, et al. Clin Exp Hypertens. 2015;37(3):241-8. doi: 10.3109/10641963.2014.954710. Epub 2014 Oct 1. Clin Exp Hypertens. 2015. PMID: 25271670 Free article.

4

Combination treatment of adipose-derived stem cells and adiponectin attenuates pulmonary arterial hypertension in rats by inhibiting pulmonary arterial smooth muscle cell proliferation and regulating the AMPK/BMP/Smad pathway.

Luo L, Zheng W, Lian G, Chen H, Li L, Xu C, Xie L. Luo L, et al. Int J Mol Med. 2018 Jan;41(1):51-60. doi: 10.3892/ijmm.2017.3226. Epub 2017 Oct 31. Int J Mol Med. 2018. PMID: 29115380 Free PMC article.

5

Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.

Zhuang W, Lian G, Huang B, Du A, Xiao G, Gong J, Xu C, Wang H, Xie L. Zhuang W, et al. Exp Biol Med (Maywood). 2018 Aug;243(12):995-1003. doi: 10.1177/1535370218794128. Epub 2018 Aug 12. Exp Biol Med (Maywood). 2018. PMID: 30099957 Free PMC article.

6

CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.

Zhuang W, Lian G, Huang B, Du A, Gong J, Xiao G, Xu C, Wang H, Xie L. Zhuang W, et al. Mol Cell Biochem. 2019 May;455(1-2):169-183. doi: 10.1007/s11010-018-3480-z. Epub 2018 Dec 3. Mol Cell Biochem. 2019. PMID: 30511343

7

RNA sequencing analysis of monocrotaline-induced PAH reveals dysregulated chemokine and neuroactive ligand receptor pathways.

Xiao G, Wang T, Zhuang W, Ye C, Luo L, Wang H, Lian G, Xie L. Xiao G, et al. Aging (Albany NY). 2020 Mar 16;12(6):4953-4969. doi: 10.18632/aging.102922. Epub 2020 Mar 16. Aging (Albany NY). 2020. PMID: 32176619 Free PMC article.

8

miR-125a-5p inhibits glycolysis by targeting hexokinase-II to improve pulmonary arterial hypertension.

Luo L, Xiao L, Lian G, Wang H, Xie L. Luo L, et al. Aging (Albany NY). 2020 May 19;12(10):9014-9030. doi: 10.18632/aging.103163. Epub 2020 May 19. Aging (Albany NY). 2020. PMID: 32427576 Free PMC article.

9

Transcriptomic analysis identifies Toll-like and Nod-like pathways and necroptosis in pulmonary arterial hypertension.

Xiao G, Zhuang W, Wang T, Lian G, Luo L, Ye C, Wang H, Xie L. Xiao G, et al. J Cell Mol Med. 2020 Oct;24(19):11409-11421. doi: 10.1111/jcmm.15745. Epub 2020 Aug 29. J Cell Mol Med. 2020. PMID: 32860486 Free PMC article.

10

Role of 20-hydroxyeicosatetraenoic acid in pulmonary hypertension and proliferation of pulmonary arterial smooth muscle cells.

Wang J, Lian G, Luo L, Wang T, Xu C, Wang H, Xie L. Wang J, et al. Pulm Pharmacol Ther. 2020 Oct;64:101948. doi: 10.1016/j.pupt.2020.101948. Epub 2020 Sep 17. Pulm Pharmacol Ther. 2020. PMID: 32949704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters